Europe's pharmaceutical industry presents a nuanced landscape rife with both opportunities. Governments across the continent are increasingly enforcing stringent regulations while patients seek accessible treatments. This fluctuating environment necessitates a proactive approach for pharmaceutical companies looking to succeed. Stakeholders must str